INDAR PrJSC is the first company in Ukraine to export pharmaceutical products with high value-added cost, namely biotechnology products and their manufacturing technologies. The company's calling card is its insulin group, including HUMODAR R100R (short-acting insulin), HUMODAR B 100R (intermediate-acting insulin) and HUMODAR C 25 100R (combination insulin), with a portfolio also including HEPARIN-INDAR (antithrombotic), Thioctodar (thioctic acid) and Protamine Sulphate (antidote), all exported to countries worldwide; INDAR PrJSC is open to cooperation in many business directions.

No hay comentarios disponibles.
Deja tu valoración & comentario